Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1990 1
1991 1
1993 1
1994 1
1995 2
1996 2
1999 2
2001 3
2003 4
2004 3
2005 2
2007 3
2008 2
2009 1
2010 2
2011 5
2012 3
2013 5
2014 5
2015 6
2016 4
2017 22
2018 37
2019 11
2020 11
2021 13
2022 8
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ponomarenko b
Search for Panamarenko B instead (3 results)
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Zhou C, Tang KJ, Cho BC, Liu B, Paz-Ares L, Cheng S, Kitazono S, Thiagarajan M, Goldman JW, Sabari JK, Sanborn RE, Mansfield AS, Hung JY, Boyer M, Popat S, Mourão Dias J, Felip E, Majem M, Gumus M, Kim SW, Ono A, Xie J, Bhattacharya A, Agrawal T, Shreeve SM, Knoblauch RE, Park K, Girard N; PAPILLON Investigators. Zhou C, et al. N Engl J Med. 2023 Nov 30;389(22):2039-2051. doi: 10.1056/NEJMoa2306441. Epub 2023 Oct 21. N Engl J Med. 2023. PMID: 37870976 Clinical Trial.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Eikelboom JW, et al. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844192 Free article. Clinical Trial.
GABAergic signaling to astrocytes in the prefrontal cortex sustains goal-directed behaviors.
Mederos S, Sánchez-Puelles C, Esparza J, Valero M, Ponomarenko A, Perea G. Mederos S, et al. Nat Neurosci. 2021 Jan;24(1):82-92. doi: 10.1038/s41593-020-00752-x. Epub 2020 Dec 7. Nat Neurosci. 2021. PMID: 33288910
However, it is largely unknown how GABAergic interneurons and astrocytes interact and contribute to stable performance of complex behaviors. Here, we found that genetic ablation of GABA(B) receptors in medial prefrontal cortex astrocytes altered low-gamma oscillations and …
However, it is largely unknown how GABAergic interneurons and astrocytes interact and contribute to stable performance of complex behaviors. …
Towards a consensus on datasets and evaluation metrics for developing B-cell epitope prediction tools.
Greenbaum JA, Andersen PH, Blythe M, Bui HH, Cachau RE, Crowe J, Davies M, Kolaskar AS, Lund O, Morrison S, Mumey B, Ofran Y, Pellequer JL, Pinilla C, Ponomarenko JV, Raghava GP, van Regenmortel MH, Roggen EL, Sette A, Schlessinger A, Sollner J, Zand M, Peters B. Greenbaum JA, et al. J Mol Recognit. 2007 Mar-Apr;20(2):75-82. doi: 10.1002/jmr.815. J Mol Recognit. 2007. PMID: 17205610 Review.
A B-cell epitope is the three-dimensional structure within an antigen that can be bound to the variable region of an antibody. ...Improving the accuracy of B-cell epitope prediction methods depends on a community consensus on the data and metrics utilized to develop …
A B-cell epitope is the three-dimensional structure within an antigen that can be bound to the variable region of an antibody. ...Imp …
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
As compared with placebo, the effects of pemafibrate on lipid levels at 4 months were -26.2% for triglycerides, -25.8% for very-low-density lipoprotein (VLDL) cholesterol, -25.6% for remnant cholesterol (cholesterol transported in triglyceride-rich lipoproteins after lipolysis an …
As compared with placebo, the effects of pemafibrate on lipid levels at 4 months were -26.2% for triglycerides, -25.8% for very-low-density …
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Stepanov AV, Belogurov AA Jr, Kothapalli P, Shamborant OG, Knorre VD, Telegin GB, Ovsepyan AA, Ponomarenko NA, Deyev SM, Kaveri SV, Gabibov AG. Stepanov AV, et al. Acta Naturae. 2015 Apr-Jun;7(2):74-9. Acta Naturae. 2015. PMID: 26085947 Free PMC article.
B cells play a crucial role in the development and pathogenesis of systemic and organ-specific autoimmune diseases. Autoreactive B cells not only produce antibodies, but also secrete pro-inflammatory cytokines and present specific autoantigens to T cells. ...
B cells play a crucial role in the development and pathogenesis of systemic and organ-specific autoimmune diseases. Autoreactive B …
Design of targeted B cell killing agents.
Stepanov AV, Belogurov AA Jr, Ponomarenko NA, Stremovskiy OA, Kozlov LV, Bichucher AM, Dmitriev SE, Smirnov IV, Shamborant OG, Balabashin DS, Sashchenko LP, Tonevitsky AG, Friboulet A, Gabibov AG, Deyev SM. Stepanov AV, et al. PLoS One. 2011;6(6):e20991. doi: 10.1371/journal.pone.0020991. Epub 2011 Jun 6. PLoS One. 2011. PMID: 21677771 Free PMC article.
B cells play an important role in the pathogenesis of both systemic and organ-specific autoimmune diseases. ...In this study we designed a repertoire of genetically engineered B cell killers that specifically affected one kind of cells carrying a respective B …
B cells play an important role in the pathogenesis of both systemic and organ-specific autoimmune diseases. ...In this study we desig …
B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study.
Tashireva LA, Popova NO, Kalinchuk AY, Goldberg VE, Kovalenko EI, Artamonova EV, Manikhas AG, Ponomarenko DM, Levchenko NV, Rossokha EI, Krasilnikova SY, Zafirova MA, Choynzonov EL, Perelmuter VM. Tashireva LA, et al. Front Oncol. 2022 Jun 23;12:909505. doi: 10.3389/fonc.2022.909505. eCollection 2022. Front Oncol. 2022. PMID: 35814376 Free PMC article.
Seven-color multiplex immunofluorescence was used to phenotype lymphocytes in the primary tumor. It has been shown that the PD1-negative-to-PD1-positive B cells ratio in primary tumors more than 3 is an independent predictor of the short-term effectiveness of eribulin [OR …
Seven-color multiplex immunofluorescence was used to phenotype lymphocytes in the primary tumor. It has been shown that the PD1-negative-to- …
Flow cytometry for pediatric platelets.
Ignatova AA, Ponomarenko EA, Polokhov DM, Suntsova EV, Zharkov PA, Fedorova DV, Balashova EN, Rudneva AE, Ptushkin VV, Nikitin EA, Shcherbina A, Maschan AA, Novichkova GA, Panteleev MA. Ignatova AA, et al. Platelets. 2019;30(4):428-437. doi: 10.1080/09537104.2018.1513473. Epub 2018 Oct 4. Platelets. 2019. PMID: 30285517
Biorecognition Layer Based On Biotin-Containing [1]Benzothieno[3,2-b][1]benzothiophene Derivative for Biosensing by Electrolyte-Gated Organic Field-Effect Transistors.
Poimanova EY, Shaposhnik PA, Anisimov DS, Zavyalova EG, Trul AA, Skorotetcky MS, Borshchev OV, Vinnitskiy DZ, Polinskaya MS, Krylov VB, Nifantiev NE, Agina EV, Ponomarenko SA. Poimanova EY, et al. ACS Appl Mater Interfaces. 2022 Apr 13;14(14):16462-16476. doi: 10.1021/acsami.1c24109. Epub 2022 Mar 31. ACS Appl Mater Interfaces. 2022. PMID: 35357127
160 results